BioSyent Schedules Q3 and YTD 2022 Earnings Release for November 16, 2022
10 nov. 2022 09h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Nov. 10, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended...
BioSyent Initiates First Dividend
12 oct. 2022 17h45 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Oct. 12, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly...
BioSyent to Present at the Virtual MicroCap Leadership Summit
14 sept. 2022 16h30 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Sept. 14, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that it has been selected to present at the 7th annual...
BioSyent Announces Adoption of Dividend Policy
23 août 2022 16h55 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 23, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors (the “Board”) today adopted a...
BioSyent Releases Q2 and H1 2022 Financial Results
23 août 2022 16h45 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 23, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and six months ended June 30, 2022. Key...
BioSyent Schedules Q2 and H1 2022 Earnings Release for August 23, 2022
16 août 2022 19h14 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, Aug. 16, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and six months ended June 30,...
BioSyent Releases Financial Results for Q1 2022
18 mai 2022 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 18, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months ended March 31, 2022. Key highlights...
BioSyent Schedules Q1 2022 Earnings Release for May 18, 2022
10 mai 2022 16h30 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 10, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2022 on...
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Seventh Consecutive Year
02 mai 2022 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 02, 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that for the seventh consecutive year, FeraMAX® is the #1 recommended iron...
Pour la septième année consécutive, FeraMAXᴹᴰ est le 1ᴱᴿ choix de marque de supplément de fer recommandée par les pharmaciens et les médecins canadiens
02 mai 2022 08h00 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, 02 mai 2022 (GLOBE NEWSWIRE) -- BioSyent Inc. (« BioSyent », Bourse de croissance TSX : RX) a le plaisir d’annoncer que pour la septième année consécutive, FeraMAXMD est le...